Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hudson Pharma is a technology-driven pharmaceutical company based in Pakistan, specializing in the development and manufacturing of high-quality generic and value-added medicines. The company is notably recognized for its advanced manufacturing capabilities in Metered Dose Inhalers (MDIs) and Dry Powder Inhalers (DPIs), positioning itself as a leader in respiratory care within the region. Beyond respiratory health, Hudson Pharma maintains a diverse portfolio across therapeutic areas including metabolic disorders, gastroenterology, and clinical nutrition. The company operates a state-of-the-art manufacturing facility designed to meet international regulatory standards, focusing on providing affordable healthcare solutions to both domestic and emerging international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hudson Pharma.